Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 17 von 279

Details

Autor(en) / Beteiligte
Titel
The G allele of SNP E1/A118G at the µµ-opioid receptor gene locus shows genomic evidence of recent positive selection
Ist Teil von
  • Pharmacogenomics, 2009-07, Vol.10 (7), p.1101-1109
Ort / Verlag
Future Medicine Ltd
Erscheinungsjahr
2009
Beschreibungen/Notizen
  • Opioid drug response and pain perception differs greatly amongst different individuals. The µµ-opioid receptor (MOR) is the main receptor target for important opioid analgesics. As SNPs may contribute to interindividual differences in drug response, signatures of recent positive selection (RPS) were utilized to seek out potentially functional SNPs in the gene in order to facilitate the prioritization of SNPs for evaluation in genetic association studies. Out of over 1000 SNPs at the locus, 184 high-frequency SNPs were interrogated for signatures of RPS. A total of five SNPs (four noncoding and one nonsynonymous coding) demonstrated evidence of RPS. Significantly, the nonsynonymous E1/A118G SNP, which was previously reported to be functionally important, showed evidence of RPS. This reaffirms the feasibility of utilizing signatures of RPS to identify potentially functionally significant SNPs for association studies. Interestingly, the positively selected G allele of this RPS SNP was also predicted to create a novel exon splice enhancer as well as p53 binding sites.
Sprache
Englisch
Identifikatoren
ISSN: 1462-2416
eISSN: 1744-8042
DOI: 10.2217/pgs.09.63
Titel-ID: cdi_futurescience_futuremedicine_10_2217_pgs_09_63

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX